SCI时时刷

search
+
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective
Given the considerable heterogeneity in neuroendocrine neoplasms (NENs), it appears unlikely that a sole biomarker exists ...
Updates in Management of Malignant Pleural Mesothelioma
Updates in Management of Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive asbestos-associated thoracic malignancy that is usually incurable. A...
The Evolving Treatment Landscape of Medullary Thyroid Cancer
The Evolving Treatment Landscape of Medullary Thyroid Cancer
Genetic assessment is crucial to address the correct treatment for advanced medullary thyroid cancer (MTC). Multi tyrosine...
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities
The primary objective of this study is to evaluate the effectiveness of cancer vaccines containing genetically modified de...
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer
Standard frontline treatment of metastatic colorectal cancer (CRC) is cytotoxic chemotherapy plus a biologic agent such as...
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Approximately 15–20% of breast cancers (BC) demonstrate HER2 overexpression/gene amplification. Historically, before...
Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor
Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor
Inflammatory myofibroblastic tumor (IMT), characterized by intermediate malignancy and a propensity for recurrence, has pr...
Frontiers of Ovarian Carcinosarcoma
Frontiers of Ovarian Carcinosarcoma
Ovarian carcinosarcoma (OCS), also known as a malignant mixed Müllerian tumour (MMMT), is a rare and aggressive form ...
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors
Transplant oncology is a new field of medicine referred to the use of solid organ transplantation, particularly the liver,...
Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a fatal blood malignancy. With the development of immunotherapy, particularly chimeric ant...
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review
The therapeutic approach of pleomorphic liposarcoma (PLPS), a rare high-grade subgroup of soft tissue sarcoma, is commonly...
Sequencing Systemic Therapy in Hepatocellular Carcinoma
Sequencing Systemic Therapy in Hepatocellular Carcinoma
Multiple treatment options are now approved for unresectable hepatocellular carcinoma (HCC). An immune checkpoint inhibito...
Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond
Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond
Cite this articlePatel, M., Hudson, O., Han, J. et al. Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint I...
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features
Strategies using immune checkpoint inhibitors (ICI), which can enhance antitumor immune responses, have revolutionized the...
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation
Esophageal cancer is a global health problem, which is 7th most common and 6th most deadly cancer. It has been the era of ...
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?
Department of Medicine, University of Melbourne, Victoria Pde, Fitzroy, Melbourne, Victoria, 3065, AustraliaJennifer Phili...
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy
Central nervous system (CNS) radiotoxicity remains a challenge in neuro-oncology. Dose distribution advantages of protons ...
The Crying Need for a Better Response Assessment in Rectal Cancer
The Crying Need for a Better Response Assessment in Rectal Cancer
Since total neoadjuvant treatment achieves almost 30% pathologic complete response, organ preservation has been increasing...
Opioid-induced Neurotoxicity in Patients with Cancer Pain
Opioid-induced Neurotoxicity in Patients with Cancer Pain
Opioid-induced neurotoxicity (OINT) is a neuropsychiatric syndrome observed with opioid therapy. The mechanism of OINT is ...
Research Progress on Pyroptosis in Hematological Malignancies
Research Progress on Pyroptosis in Hematological Malignancies
Pyroptosis is a kind of programmed cell death dependent on the caspase pathway that is different from apoptosis and necros...
Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond
Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond
Immunotherapy is an innovative approach to cancer treatment that involves using the body’s immune system to fight ca...
Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer
Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer
Prostate cancer (PCa) is the second most diagnosed malignant neoplasm and is one of the leading causes of cancer-related d...
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia
Increasing understanding of the complex interaction between leukemic and immune cells, which is responsible for tumor prog...
Cardio-oncology in China
Cardio-oncology in China
Cardio-oncology is going under rapid development in various areas across an increasing number of provinces in China. Howev...
An Update on Temporal Bone Paragangliomas
An Update on Temporal Bone Paragangliomas
Temporal bone paragangliomas (TBPs) are indolent, classically benign and highly vascular neoplasms of the temporal bone. T...
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
Combining immunotherapy and radiotherapy as a treatment strategy for cervical cancer has attracted increasing attention. T...
Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?
Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?
In considering the impact of medically hastened death (MHD) on cancer care, a wide range of variables needs to be consider...
Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review
Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review
Systemic anticancer therapy (SACT) includes different treatment modalities that can be effective in treating cancer. Howev...
Gastric Cancer with Sarcopenia: an Area Worth Focusing On
Gastric Cancer with Sarcopenia: an Area Worth Focusing On
Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer death worldwide, which seriously...
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?
Approximately 20% of breast cancers overexpress human epidermal growth factor receptor 2 (HER2+), conferring a particularl...
阅读更多
format_indent_increase